| 2026-05-05 |
详情>>
内部人交易：
Wedel Christensen Jakob共交易2笔
|
| 2026-05-04 |
详情>>
股本变动：
变动后总股本15130.00万股
|
| 2026-05-04 |
详情>>
业绩披露：
2026年一季报每股收益0.88美元,归母净利润1.34亿美元,同比去年增长2.29%
|
| 2026-04-30 |
财报披露：
美东时间 2026-04-30 盘后发布财报
|
| 2026-04-09 |
股东大会：
将于2026-05-21召开股东大会
会议内容 ▼▲
- 1.Elect nine nominees to hold office for one year or until his or her successor is elected;
2.Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending January 3, 2027;
3.Hold a vote to approve, on an advisory basis, the compensation provided to our “named executive officers” as disclosed in this proxy statement.
4.Transact such other business as may properly come before the meeting and any adjournment or postponement thereof.
|
| 2026-02-12 |
详情>>
业绩披露：
2023年年报每股收益-7.34美元,归母净利润-11.61亿美元,同比去年增长73.64%
|
| 2026-02-12 |
详情>>
业绩披露：
2025年年报每股收益5.47美元,归母净利润8.50亿美元,同比去年增长169.50%
|
| 2025-10-31 |
详情>>
业绩披露：
2025年三季报(累计)每股收益3.30美元,归母净利润5.16亿美元,同比去年增长136.60%
|
| 2025-08-01 |
详情>>
业绩披露：
2025年中报每股收益2.32美元,归母净利润3.66亿美元,同比去年增长117.31%
|
| 2025-05-09 |
详情>>
业绩披露：
2025年一季报每股收益0.83美元,归母净利润1.31亿美元,同比去年增长203.97%
|
| 2025-04-09 |
股东大会：
将于2025-05-21召开股东大会
会议内容 ▼▲
- 1.Elect eleven nominees to our Board of Directors;
2.Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 28, 2025;
3.Hold an advisory vote to approve the compensation provided to the “named executive officers” as disclosed in the accompanying proxy statement;
4.Hold a vote to approve the Second Amended and Restated 2015 Stock and Incentive Plan of Illumina, Inc.;
5.Transact such other business as may properly come before the meeting and any adjournment or postponement thereof.
|
| 2025-02-12 |
详情>>
业绩披露：
2024年年报每股收益-7.69美元,归母净利润-12.23亿美元,同比去年增长-5.34%
|
| 2025-02-12 |
详情>>
业绩披露：
2022年年报每股收益-28美元,归母净利润-44.04亿美元,同比去年增长-677.95%
|
| 2024-11-06 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-8.86美元,归母净利润-14.1亿美元,同比去年增长-43%
|
| 2024-08-07 |
详情>>
业绩披露：
2024年中报每股收益-13.28美元,归母净利润-21.14亿美元,同比去年增长-815.15%
|
| 2024-05-03 |
详情>>
业绩披露：
2024年一季报每股收益-0.79美元,归母净利润-1.26亿美元,同比去年增长-4300%
|
| 2024-04-04 |
股东大会：
将于2024-05-16召开股东大会
会议内容 ▼▲
- 1.Elect eleven nominees to our Board of Directors;
2.Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 29, 2024;
3.Hold an advisory vote to approve the compensation provided to the “named executive officers” as disclosed in the accompanying proxy statement;
4.Transact such other business as may properly come before the meeting and any adjournment or postponement thereof.
|
| 2023-04-20 |
股东大会：
将于2023-05-25召开股东大会
会议内容 ▼▲
- 1.Elect nine nominees to our Board of Directors;
2.Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023;
3.Hold an advisory vote to approve the compensation provided to the “named executive officers” as disclosed in the proxy statement;
4.Hold an advisory vote on the frequency of holding an advisory vote to approve compensation provided to our “named executive officers”;
5.Hold a vote to approve certain amendments to the Illumina, Inc. 2015 Stock and Incentive Plan;
6.Transact such other business as may properly come before the meeting and any adjournment or postponement.
|
| 2023-04-20 |
股东大会：
将于2023-05-25召开股东大会
会议内容 ▼▲
- 1.Elect nine nominees to our Board of Directors;
2.Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023;
3.Hold an advisory vote to approve the compensation provided to the “named executive officers” as disclosed in the proxy statement;
4.Hold an advisory vote on the frequency of holding an advisory vote to approve compensation provided to our “named executive officers”;
5.Hold a vote to approve certain amendments to the Illumina, Inc. 2015 Stock and Incentive Plan;
6.Transact such other business as may properly come before the meeting and any adjournment or postponement.
|
| 2022-04-14 |
股东大会：
将于2022-05-26召开股东大会
会议内容 ▼▲
- 1.Elect the nine nominees named in the proxy statement to our Board of Directors;
2.Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending January 1, 2023;
3.Hold an advisory vote to approve the compensation provided to the “named executive officers” as disclosed in the proxy statement;
4.Hold an advisory vote on a stockholder proposal regarding the right of stockholders to call special meetings;
5.Hold a vote to approve an amendment and restatement of our Certificate of Incorporation to permit stockholders to call special meetings;
6.Transact such other business as may properly come before the meeting and any adjournment or postponement.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-16 |
股东大会：
将于2021-05-26召开股东大会
会议内容 ▼▲
- 1.Elect the four nominees named in the proxy statement to our Board of Directors;
2.Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending January 3, 2021;
3.Hold an advisory vote to approve the compensation paid to the “named executive officers” as disclosed in the proxy statement;
4.Hold an advisory vote on a stockholder proposal regarding political disclosures;
5.Transact such other business as may properly come before the meeting and any adjournment or postponement.
|
| 2020-09-21 |
复牌提示：
2020-09-21 06:55:10 停牌，复牌日期 2020-09-21 07:20:00
|
| 2020-04-16 |
股东大会：
将于2020-05-27召开股东大会
会议内容 ▼▲
- 1.Elect the four nominees named in the proxy statement to our Board of Directors;
2.Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending January 3, 2021;
3.Hold an advisory vote to approve the compensation paid to the “named executive officers” as disclosed in the proxy statement;
4.Hold an advisory vote on a stockholder proposal regarding political disclosures;
5.Transact such other business as may properly come before the meeting and any adjournment or postponement.
|
| 2019-04-16 |
股东大会：
将于2019-05-29召开股东大会
会议内容 ▼▲
- 1.Elect the three nominees named in the proxy statement to our Board of Directors;
2.Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 29, 2019;
3.Hold an advisory vote to approve the compensation paid to the “named executive officers” as disclosed in the proxy statement;
4.Hold a vote to approve an amendment to our Amended and Restated Certificate of Incorporation to declassify our Board of Directors;
5.Hold an advisory vote on a stockholder proposal to enhance election-related disclosures;
6.Transact such other business as may properly come before the meeting and any adjournment or postponement.
|
| 2018-04-06 |
股东大会：
将于2018-05-23召开股东大会
会议内容 ▼▲
- 1.Elect the three nominees named in the proxy statement to our Board of Directors;
2.Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 30, 2018;
3.Hold an advisory vote to approve the compensation paid to the “named executive officers” as disclosed in the proxy statement;
4.Hold an advisory vote on a stockholder proposal to elect each director annually;
5.Transact such other business as may properly come before the meeting and any adjournment or postponement.
|
| 2017-04-14 |
股东大会：
将于2017-05-30召开股东大会
会议内容 ▼▲
- 1.Elect the three nominees named in the proxy statement to our Board of Directors;
2.Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2017;
3.Hold an advisory vote to approve the compensation paid to the “named executive officers” as disclosed in the proxy statement;
4.Hold an advisory vote on the frequency of future advisory votes to approve the compensation of our “named executive officers”;
5.Hold a vote to approve an amendment to our certificate of incorporation to remove certain supermajority voting requirements;
6.Transact such other business as may properly come before the meeting and any adjournment or postponement.
|